These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17210972)

  • 1. Differential diagnosis of Parkinson's disease: a new blood test?
    Hiner BC
    Clin Med Res; 2006 Dec; 4(4):246-7. PubMed ID: 17210972
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease.
    Pellecchia MT; Pivonello R; Colao A; Barone P
    Clin Med Res; 2006 Dec; 4(4):322-5. PubMed ID: 17210980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia.
    Pellecchia MT; Salvatore E; Pivonello R; Faggiano A; Barone P; De Michele G; Colao AM; Filla A
    Neurol Sci; 2001 Feb; 22(1):79-80. PubMed ID: 11487211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is clonidine-growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
    Mathias CJ; Kimber J; Watson L; Muthane U
    J Neurol; 2002 Apr; 249(4):488-9. PubMed ID: 11967661
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine-growth-hormone testing in Parkinson's disease.
    Mathias CJ; Kimber JR
    Lancet; 1999 Jul; 354(9175):339-40. PubMed ID: 10440340
    [No Abstract]   [Full Text] [Related]  

  • 7. The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease.
    Zhang K; Zeng Y; Song C; Fu Y; Wan Q
    J Neurol; 2010 Sep; 257(9):1486-91. PubMed ID: 20405138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
    Tranchant C; Guiraud-Chaumeil C; Echaniz-Laguna A; Warter JM
    J Neurol; 2000 Nov; 247(11):853-6. PubMed ID: 11151417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of the clonidine growth hormone stimulation test to differentiate multiple system atrophy from early or advanced idiopathic Parkinson's disease.
    Clarke CE; Ray PS; Speller JM
    Lancet; 1999 Apr; 353(9161):1329-30. PubMed ID: 10218537
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
    Kimber JR; Watson L; Mathias CJ
    Lancet; 1997 Jun; 349(9069):1877-81. PubMed ID: 9217760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of microRNAs for the early diagnosis of Parkinson's disease and multiple system atrophy.
    Yan JH; Hua P; Chen Y; Li LT; Yu CY; Yan L; Zhang H; He Y; Zheng H; Chen H; Zhang ZJ; Yao QH; Dong H; Liu WG
    J Integr Neurosci; 2020 Sep; 19(3):429-436. PubMed ID: 33070521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration.
    Strijks E; van't Hof M; Sweep F; Lenders JW; Oyen WJ; Horstink MW
    J Neurol; 2002 Sep; 249(9):1206-10. PubMed ID: 12242540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine test is not reliable for diagnosing cerebellar multiple system atrophy.
    Gardner RC; Schmahmann JD
    Ann Neurol; 2010 Mar; 67(3):404-8. PubMed ID: 20373353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A patient with a parkinsonian syndrome illustrating the difficult differential diagnosis between multisystem atrophy and Parkinson's disease.
    Caranci G; Ruggieri S; Manfredi M; Modugno N; Castellano AE
    Mov Disord; 2008 Oct; 23(14):2103-4. PubMed ID: 18709674
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic effects of clonidine in two contrasting models of autonomic failure: multiple system atrophy and pure autonomic failure.
    Young TM; Asahina M; Watson L; Mathias CJ
    Mov Disord; 2006 May; 21(5):609-15. PubMed ID: 16404729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early distinction of Parkinson-variant multiple system atrophy from Parkinson's disease.
    Fanciulli A; Goebel G; Lazzeri G; Scherfler C; Gizewski ER; Granata R; Kiss G; Strano S; Colosimo C; Pontieri FE; Kaufmann H; Seppi K; Poewe W; Wenning GK
    Mov Disord; 2019 Mar; 34(3):440-441. PubMed ID: 30788854
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiating multiple-system atrophy from Parkinson's disease.
    Ramli N; Nair SR; Ramli NM; Lim SY
    Clin Radiol; 2015 May; 70(5):555-64. PubMed ID: 25752581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of relevance of
    Alves Do Rego C; Namer IJ; Marcel C; Lefebvre F; Lagha-Boukbiza O; Renaud M; Tranchant C; Anheim M
    J Neurol; 2018 Sep; 265(9):2033-2039. PubMed ID: 29956027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separating the primary autonomic failure syndromes, multiple system atrophy, and pure autonomic failure from Parkinson's disease.
    Mathias CJ; Polinsky RJ
    Adv Neurol; 1999; 80():353-61. PubMed ID: 10410741
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
    Lee EA; Kim BJ; Lee WY
    Mov Disord; 2002 Nov; 17(6):1242-7. PubMed ID: 12465063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.